Dr. Desai discusses his AAD 2022 presentation, which focused on a variety of new non-hydroquinone therapies for melasma.
Dr. Silverberg provides a few patient counseling pearls for patients being treated with JAK inhibitors
Dr. Parker discussed her session that she directed at the AAD 2023 Annual Meeting, which
Dr. Elbuluk reviews a topic from one of her talks at the AAD Annual Meeting
Dr. Friedman reviews issues in lichen planus discussed during his session at the AAD 2023
Dr. Harper reviews a presentation she delivered at the AAD 2023 Annual Meeting, in which
Dr. Bhatia provides a recap of his sessions delivered at the AAD Annual Meeting, including
Dr. Sidbury discusses one of his presentations from the AAD 2023 Annual Meeting, in which
Dr. Friedman reviews one of his sessions from the AAD 2023 Annual Meeting, in which
Dr. Lio reviews one of his sessions presented at the AAD 2023 Annual Meeting, in
Dr. Alexis discusses a few topics covered during his sessions delivered at the AAD Annual
Dr. Del Rosso reviews his session from the AAD 2023 Annual Meeting, in which he
Dr. Lim discusses two topics covered in his sessions delivered at the AAD 2023 Annual
Dr. Baldwin discusses her session delivered at the AAD 2023 Annual Meeting, in which she
Dr. Lee discusses the topics covered during her session, “Technology in Dermatology: Tailoring Solutions to
Dr. Chovatiya recaps his session titled, “Itch Tales: Looking Beyond Atopic Dermatitis,” in which he
JCAD’s coverage of the 2023 AAD Annual Meeting is not endorsed by or affiliated with the American Academy of Dermatology (AAD).
